Skip to main content
Premium Trial:

Request an Annual Quote

Enigma Diagnostics Gets $3.3M Grant from UK Government

NEW YORK (GenomeWeb News) – Enigma Diagnostics has received a £1.8 million ($3.3 million) grant from the UK government’s Technology Strategy Board to help the firm develop its portable molecular diagnostics system.
 
The Porton Down, UK-based firm is developing a rapid, point-of-care system that will run DNA-based tests for infectious diseases. The funding will support its program to develop tests for sexually transmitted diseases, such as chlamydia, and healthcare-associated infections, such as methicillin-resistant Steprococcus aureus.
 
The company's portable, rapid, automated DNA analysis, or PRADA, system is based on proprietary technology, while real-time molecular assays for the instrument are being developed by researchers at the Centre for Healthcare Associated Infections at Nottingham University and Nottingham Trent University.
 
Privately held Enigma said that it holds an exclusive license to a portfolio of patents from the UK Ministry of Defence, as well as licenses from Applied Biosystems and Celera for the commercialization of real-time PCR instruments.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.